Literature DB >> 26825675

Non-exophytic Lambl excrescences of aortic valves: a morphological study.

Susumu Matsukuma1,2, Ayano Koga1, Hiroaki Takeo1, Kimi Kato1, Kazuma Mori1, Kimiya Sato1.   

Abstract

AIMS: To elucidate the histopathological findings of classical Lambl excrescences (LEs) and non-exophytic LEs (non-ex LEs) without excrescent papillary features. METHODS AND
RESULTS: We examined 126 aortic valves (AVs) and revealed LEs (non-ex and/or classical), non-ex LEs and classical LEs in 106, 78 and 88 AVs, respectively. The detection of non-ex LEs was challenging, but elastica van Gieson stain highlighted their presence. Non-ex and classical LEs chiefly involved the ventricular regions, favoured posterior cusps and coexisted in the same areas of 31 AVs. A possible transformation of classical LEs into non-ex LEs was suggested histologically in 39 AVs. Non-ex LEs were associated with age of >70 years (P < 0.001) and marked deformity (P = 0.007). Classical LEs were associated inversely with marked deformity (P < 0.001), but not with age of >70 years. Compared with age- and sex-matched control AVs, non-ex LEs and marked deformity in dysfunctional AVs were more common (P = 0.037 and P < 0.001, respectively), but classical LEs were less common (P = 0.021).
CONCLUSIONS: Non-ex LEs have subtle features but are a common form of LEs, and seem to develop from classical LEs. AV dysfunction-related marked deformity can promote non-ex LEs.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Lambl excrescence; aortic valve; papillary fibroelastoma

Mesh:

Year:  2016        PMID: 26825675     DOI: 10.1111/his.12938

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  1 in total

1.  An Autopsy Case of Lambl's Excrescences with Trousseau Syndrome that Caused Cardioembolic Stroke.

Authors:  Takehisa Hirayama; Harumi Morioka; Hideomi Fujiwara; Konosuke Iwamoto; Tetsuhito Kiyozuka; Hiroteru Takeo; Ken Ikeda; Osamu Kano
Journal:  Intern Med       Date:  2020-08-04       Impact factor: 1.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.